| scholarly article | Q13442814 |
| P50 | author | Steven Shoptaw | Q42603579 |
| P2093 | author name string | Walter Ling | |
| Xiaowei Yang | |||
| Erin J Rotheram-Fuller | |||
| Prudencia C Kintaudi | |||
| V C Charuvastra | |||
| Ya-Ching M Hsieh | |||
| P433 | issue | 12 | |
| P921 | main subject | placebo | Q269829 |
| cocaine dependence | Q3743188 | ||
| placebo-controlled trial | Q108853737 | ||
| P304 | page(s) | 1440-1448 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. | |
| P478 | volume | 64 |
| Q38634675 | A New Insight into the Role of CART in Cocaine Reward: Involvement of CaMKII and Inhibitory G-Protein Coupled Receptor Signaling |
| Q35144056 | A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence |
| Q37163680 | Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study |
| Q34389125 | Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference |
| Q28270110 | Agents in development for the management of cocaine abuse |
| Q33927470 | Anti-relapse medications: preclinical models for drug addiction treatment |
| Q37085367 | Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse? |
| Q35914931 | Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons |
| Q45210464 | Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates |
| Q41879795 | Baclofen in the management of cannabis dependence syndrome |
| Q36474092 | Baclofen in the management of inhalant withdrawal: a case series. |
| Q34739209 | Baclofen in the short-term maintenance treatment of benzodiazepine dependence |
| Q33989807 | Baclofen reduces fat intake under binge-type conditions |
| Q35792386 | Bacterial Cocaine Esterase: A Protein-Based Therapy for Cocaine Overdose and Addiction |
| Q35585627 | Bingeing rats: a model of intermittent excessive behavior? |
| Q36938316 | Biological treatments for amfetamine dependence : recent progress |
| Q36358858 | Clinical potential of GABAB receptor modulators. |
| Q37087986 | Controversies in translational research: drug self-administration |
| Q37172186 | Differential effects of allopregnanolone on the escalation of cocaine self-administration and sucrose intake in female rats |
| Q90438743 | Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling |
| Q37765942 | Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. |
| Q37705299 | Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats |
| Q40567047 | Effects of fendiline on cocaine-seeking behavior in the rat. |
| Q36952858 | Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats |
| Q37062538 | Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research |
| Q22242633 | Future pharmacological treatments for substance use disorders |
| Q34528033 | GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine |
| Q83011389 | Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects |
| Q37183687 | Hypothesis-driven medication discovery for the treatment of psychostimulant addiction |
| Q35947830 | Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: A longitudinal perfusion fMRI study |
| Q34607261 | Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals |
| Q26782278 | Neural substrates of cue reactivity: association with treatment outcomes and relapse |
| Q35894612 | Neurobiologic processes in drug reward and addiction |
| Q46902878 | New developments in the pharmacotherapy of cocaine dependence |
| Q36009882 | Novel approaches to the treatment of cocaine addiction |
| Q34065088 | Novel pharmacotherapeutic treatments for cocaine addiction |
| Q34667835 | Novel psychoactive substances of interest for psychiatry. |
| Q26853630 | Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation |
| Q37385834 | Pathological Gambling: Neuropsychopharmacology and Treatment |
| Q34982551 | Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine |
| Q26991936 | Pharmacotherapy of amphetamine‐type stimulant dependence: An update |
| Q36751967 | Pharmacotherapy of dual substance abuse and dependence |
| Q36341673 | Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy |
| Q30438149 | Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function |
| Q35882073 | Recent advances in the pharmacotherapy of cocaine dependence |
| Q37351971 | Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules. |
| Q34770872 | Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats |
| Q37024182 | Review. Evidence-based treatments of addiction |
| Q48167663 | Selective inhibition of M5 muscarinic acetylcholine receptors attenuates cocaine self-administration in rats |
| Q37294513 | Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls |
| Q42736798 | Surface expression of GABAA receptors in the rat nucleus accumbens is increased in early but not late withdrawal from extended-access cocaine self-administration |
| Q33757216 | The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. |
| Q33677986 | The Health Effect of Psychostimulants: A Literature Review |
| Q60920774 | The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective |
| Q37416909 | The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. |
| Q35624709 | The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research |
| Q35454891 | Therapeutic options and challenges for substances of abuse. |
| Q26864995 | Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling |
| Q24633145 | Topiramate in the treatment of substance-related disorders: a critical review of the literature |
| Q37386522 | Treatment of co-occurring alcohol and other drug use disorders |
| Q37267352 | Valproate treatment and cocaine cue reactivity in cocaine dependent individuals |
Search more.